Zymeron
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
400 Park Offices Dr Ste 211, Durham, Nor...Phone Number
(919) 748-3319Website
www.zymeron.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Zymeron
Zymeron is a preclinical pharmaceutical startup focused on developing myeloprotective, cardioprotective, and neuroprotective drugs aimed at enhancing the health of hematopoietic, cardiovascular, and cerebrovascular systems. Their MyeloShield Therapeutics is designed to transform the management of myelosuppression and cytopenia for chemotherapy patients, shifting from reactive to preventive care. The company also specializes in innovative drug delivery systems, including a proprietary peptide drug conjugate that protects stem cells from chemotherapy-induced damage. Zymeron collaborates with various partners across academia, industry, and government to address unmet clinical needs and advance health-related technologies.Explore more
Zymeron Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Zymeron your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Zymeron has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Zymeron launches new products
Zymeron, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Zymeron
Funding: Get notified immidiatlly once Zymeron has new funding data
Earning: See what the market has to say on Zymeron recently announced quarterly report
Check out if Zymeron is spiking on competitors!
Click to see if Zymeron had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Zymeron as Masked Content
Find 2 more new buyers
Compare Similar Companies to Zymeron
Compare insights from companies similar to Zymeron, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Zymeron is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Zymeron is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zymeron.
Zymeron Tech Stack
A closer look at the technologies used by Zymeron
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Clinical Operations, Operations
Funding
Project
Spending/Investment, Funding
Funding
Project
Award, Spending/Investment
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Zymeron
Sign Up For FreeTo access detailed company insights
Zymeron is a preclinical pharmaceutical startup focused on developing myeloprotective, cardioprotective, and neuroprotective drugs aimed at enhancing the health of hematopoietic, cardiovascular, and cerebrovascular systems. Their MyeloShield Therapeutics is designed to transform the management of myelosuppression and cytopenia for chemotherapy pati... Read More
